The GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide sit behind the STEP (NEJM, 2021), SURMOUNT (NEJM, 2022), and SURMOUNT-OSA (NEJM, 2024) evidence, and the clinical picture does not change with the price tag
This is also why nausea is the most common side effect
Free radicals are produced by: Pollution and UV exposure Stress and lack of sleep Poor diet and smoking Normal metabolic processes When free radicals overwhelm the bodys defence system, oxidative stress occurs
This is not a hypothetical concern
Its high enough to deliver measurable benefits and flexible enough to be used safely once, twice, or even three times daily under medical supervision
Most adults enter weight loss with some degree of insulin resistance from years of eating a standard high-carbohydrate diet